Workflow
New Found Gold Closes First Tranche of C$56 Million Bought Deal Financing for Gross Proceeds of C$42 Million
New Found Gold New Found Gold (US:NFGC) Prnewswireยท2025-06-03 12:45

Core Viewpoint - New Found Gold Corp. has successfully closed the first tranche of its public offering, raising a total of C$56,129,100 through the issuance of charity flow-through common shares and common shares [1][2][4]. Group 1: Offering Details - The first tranche of the offering included 15,265,000 charity flow-through common shares and 4,370,000 common shares, generating gross proceeds of C$42,079,950 [2]. - The second tranche will consist of an additional 6,135,000 charity flow-through common shares, expected to raise C$14,049,150, and is anticipated to close around June 12, 2025 [4]. - The total gross proceeds from both tranches will be used for Canadian exploration expenses related to the Queensway Gold Project [8]. Group 2: Underwriting and Fees - The offering was conducted under an underwriting agreement with a syndicate led by BMO Capital Markets and included several other financial institutions [3]. - The company paid the underwriters a cash fee of C$2,075,959, which is 5.25% of the gross proceeds from the first tranche, excluding certain sales [7]. Group 3: Use of Proceeds - Proceeds from the charity flow-through common shares will be allocated to eligible Canadian exploration expenses related to the Queensway Gold Project, with all qualifying expenditures to be renounced in favor of the subscribers by December 31, 2025 [8]. - The net proceeds from the common shares will be utilized to advance the Queensway Project and for general corporate purposes [9]. Group 4: Company Background - New Found Gold holds a 100% interest in the Queensway Gold Project, located in Newfoundland and Labrador, which is recognized for its excellent infrastructure and skilled workforce [13]. - The company has completed an initial mineral resource estimate at Queensway and is currently conducting a fully funded preliminary economic assessment [13][14].